Business Wire·Nov 13, 2026, 8:05 AM ET

HealthWarehouse.com Reports Results for Third Quarter 2026

HealthWarehouse.com, Inc. reported third-quarter 2026 net sales of $6.51 million, a 23% decrease from the same period in 2025.
The company recorded a net loss of $240,000 for the quarter, compared to a net loss of $72,000 in the prior year period.
Adjusted EBITDA for the third quarter was $123,000, down from $384,000 in the third quarter of 2025.
Prescription sales dropped to $5.4 million in the quarter due to the FDA ending a nationwide program allowing compounded GLP-1 medications in early 2025.
Over-the-counter product sales increased by 42.4% to $934,000, driven primarily by higher advertising spend.
Gross margin percentages rose to 55.1% for the quarter, an increase of 12.4 percentage points compared to the prior year.
The company is extending its strategic partnership with healthwords.ai into 2027 to integrate artificial intelligence tools for operational efficiency.
Colonial Stock Transfer Company, Inc. was appointed as the new transfer agent with headquarters in Sandy, Utah.
Nine-month net sales totaled $19.0 million, a 51.5% decrease from $39.1 million in the same period of 2025.
Adjusted EBITDA for the nine-month period was $11,000, a significant decline from $1.6 million in the prior year.